GW Pharmaceuticals

E874301

GW Pharmaceuticals is a biopharmaceutical company known for pioneering cannabis-based prescription medicines, including the epilepsy treatment Epidiolex.

All labels observed (1)

Label Occurrences
GW Pharmaceuticals canonical 3

How this entity was disambiguated

Statements (49)

Predicate Object
instanceOf biopharmaceutical company
public company
acquiredBy Jazz Pharmaceuticals
acquisitionDate 2021-05-05
acquisitionValue 7200000000 USD
country United Kingdom
delistedFrom London Stock Exchange
NASDAQ
develops cannabinoid-based prescription medicines
EpidiolexActiveIngredient cannabidiol
EpidiolexFormulation oral solution
EpidiolexIndication Dravet syndrome
Lennox-Gastaut syndrome
tuberous sclerosis complex
focusesOn multiple sclerosis symptom management
rare and severe forms of epilepsy
formerHeadquartersLocation Porton Down, Wiltshire, United Kingdom
foundedBy Brian Whittle
Geoffrey Guy
hasSubsidiary GW Research Ltd
headquartersLocation Cambridge, United Kingdom
linked to: Cambridge, England
inception 1998
industry biotechnology industry
pharmaceutical industry
legalForm public limited company
listedOn London Stock Exchange
locatedInTimeZone Europe/London
notableFor first FDA-approved plant-derived cannabinoid medicine
notableProduct Epidiolex
Sativex
parentOrganization Jazz Pharmaceuticals
partOf cannabis industry
regulatoryApproval Epidiolex EMA approval 2019
Epidiolex FDA approval 2018
Sativex approvals in multiple countries
regulatoryBodyInteraction European Medicines Agency
U.S. Food and Drug Administration
researchArea cannabinoid science
central nervous system disorders
SativexActiveIngredients cannabidiol
tetrahydrocannabinol
SativexFormulation oromucosal spray
SativexIndication multiple sclerosis spasticity
specializesIn cannabis-based medicines
epilepsy treatments
neurology
stockExchange NASDAQ
tickerSymbol GWPH
website https://www.gwpharm.com/

How these facts were elicited

Referenced by (3)

Full triples — surface form annotated when it differs from this entity's canonical label.

Epidiolex developedBy GW Pharmaceuticals
Jazz Pharmaceuticals hasSubsidiary GW Pharmaceuticals
Jazz Pharmaceuticals acquired GW Pharmaceuticals